Condition
Epithelioid Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatoid Mesothelioma|Stage II Pleural Mesothelioma|Stage III Pleural Mesothelioma|Stage IV Pleural Mesothelioma
Estimated Enrollment: 18
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NCI-2013-00937|12-2158|9267|N01CM00071|P30CA014599
Study First Received: May 20, 2013
Last Updated: August 26, 2016
Estimated Primary Completion Date: March 2015
Primary Outcome Measures:
Objective Radiologic Response Rate (Complete or Partial Response) Assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1|Incidence of Adverse Events, Graded Per NCI CTCAE Version 4|Overall Survival|Progression-free Survival
Sponsors and Collaborators:
National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT01861301